Compile Data Set for Download or QSAR
maximum 50k data
Found 295 with Last Name = 'orry' and Initial = 'a'
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataKi:  25nMAssay Description:Displacement of [125I-BDZ-2] from wild-type human CCK2R at allosteric site expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataKi:  25nMAssay Description:Displacement of [125I-CCK] from wild-type human CCK1R at allosteric site expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataKi:  29nMAssay Description:Displacement of [125I-CCK] from wild-type human CCK1R at allosteric site expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetLethal factor(Bacillus anthracis)
Burnham Institute For Medical Research

LigandPNGBDBM8443(2-[(5Z)-5-({5-[2-chloro-5-(trifluoromethyl)phenyl]...)
Affinity DataKi:  32nMAssay Description:Fluorescence peptide cleavage assay was performed in a 96-well plate. Each reaction contained MAPKKide, LF, and the small-molecule inhibitor. The C-t...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataKi:  69nMAssay Description:Displacement of [125I-BDZ-2] from wild-type human CCK2R at allosteric site expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataKi:  71nMAssay Description:Displacement of [125I-CCK] from wild-type human CCK2R at allosteric site expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataKi:  166nMAssay Description:Displacement of [125I-BDZ-1] from wild-type human CCK1R at allosteric site expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataKi:  170nMAssay Description:Displacement of [125I-BDZ-2] from wild-type human CCK2R expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataKi:  214nMAssay Description:Displacement of [125I-CCK] from wild-type human CCK2R at allosteric site expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataKi:  214nMAssay Description:Displacement of [125I-CCK] from wild-type human CCK1R expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataKi:  275nMAssay Description:Displacement of [125I-CCK] from wild-type human CCK1R expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataKi:  427nMAssay Description:Displacement of [125I-BDZ-1] from wild-type human CCK1R expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetLethal factor(Bacillus anthracis)
Burnham Institute For Medical Research

LigandPNGBDBM8435(3-[(5Z)-5-{[5-(4-chlorophenyl)furan-2-yl]methylide...)
Affinity DataKi:  800nM IC50:  1.70E+3nMAssay Description:Fluorescence peptide cleavage assay was performed in a 96-well plate. Each reaction contained MAPKKide, LF, and the small-molecule inhibitor. The C-t...More data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataKi:  912nMAssay Description:Displacement of [125I-BDZ-1] from wild-type human CCK1R at allosteric site expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataKi: <1.00E+3nMAssay Description:Displacement of [125I-CCK] from wild-type human CCK2R expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataKi: <1.00E+3nMAssay Description:Displacement of [125I-BDZ-1] from wild-type human CCK1R expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataKi:  1.26E+3nMAssay Description:Displacement of [125I-BDZ-2] from wild-type human CCK2R expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataKi:  1.41E+3nMAssay Description:Displacement of [125I-CCK] from wild-type human CCK2R expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelanin-concentrating hormone receptor 1(Homo sapiens (Human))
Molsoft

Curated by ChEMBL
LigandPNGBDBM50232469(CHEMBL252145 | N,N-bis(tosylmethyl)hexan-1-amine)
Affinity DataKi:  1.70E+3nMAssay Description:Displacement of [125I]MCH from human MCHR1 expressed in CHO cell membranesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelanin-concentrating hormone receptor 1(Homo sapiens (Human))
Molsoft

Curated by ChEMBL
LigandPNGBDBM50232467(CHEMBL399303 | phenyl-N,N-bis(tosylmethyl)methanam...)
Affinity DataKi:  7.50E+3nMAssay Description:Displacement of [125I]MCH from human MCHR1 expressed in CHO cell membranesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelanin-concentrating hormone receptor 1(Homo sapiens (Human))
Molsoft

Curated by ChEMBL
LigandPNGBDBM50232470(2-phenyl-N,N-bis(o-tolylthiomethyl)ethanamine | CH...)
Affinity DataKi:  7.50E+3nMAssay Description:Displacement of [125I]MCH from human MCHR1 expressed in CHO cell membranesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelanin-concentrating hormone receptor 1(Homo sapiens (Human))
Molsoft

Curated by ChEMBL
LigandPNGBDBM50232468(6-(((3-chlorobenzyl)(methyl)amino)methyl)-N2-o-tol...)
Affinity DataKi:  7.80E+3nMAssay Description:Displacement of [125I]MCH from human MCHR1 expressed in CHO cell membranesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelanin-concentrating hormone receptor 1(Homo sapiens (Human))
Molsoft

Curated by ChEMBL
LigandPNGBDBM50232466(2-(dimethylamino)ethyl 4-(5-(4-methoxybenzylidene)...)
Affinity DataKi:  8.10E+3nMAssay Description:Displacement of [125I]MCH from human MCHR1 expressed in CHO cell membranesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelanin-concentrating hormone receptor 1(Homo sapiens (Human))
Molsoft

Curated by ChEMBL
LigandPNGBDBM50232465(4-methoxy-benzoic acid 2-diethylaminomethyl-4-(1,1...)
Affinity DataKi:  1.13E+4nMAssay Description:Displacement of [125I]MCH from human MCHR1 expressed in CHO cell membranesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelanin-concentrating hormone receptor 1(Homo sapiens (Human))
Molsoft

Curated by ChEMBL
LigandPNGBDBM50232464(CHEMBL251947 | {3-[2-(4-bromo-phenyl)-benzo[d]imid...)
Affinity DataKi:  1.19E+4nMAssay Description:Displacement of [125I]MCH from human MCHR1 expressed in CHO cell membranesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelanin-concentrating hormone receptor 1(Homo sapiens (Human))
Molsoft

Curated by ChEMBL
LigandPNGBDBM50232471(CHEMBL251948 | N-(3-(benzyl(isopropyl)amino)propyl...)
Affinity DataKi:  2.09E+4nMAssay Description:Displacement of [125I]MCH from human MCHR1 expressed in CHO cell membranesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataIC50:  0.813nMAssay Description:Displacement of [125I-CCK] from human CCK1R N2.61T mutant expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataIC50:  1.40nMAssay Description:Displacement of [125I-CCK] from human CCK1R W6.48A mutant expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataIC50:  1.70nMAssay Description:Displacement of [125I-CCK] from human CCK2R H7.39L mutant expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataIC50:  2nMAssay Description:Displacement of [125I-CCK] from human CCK1R N2.61T mutant expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataIC50:  2nMAssay Description:Displacement of [125I-BDZ-2] from human CCK2R H7.39L mutant expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataIC50:  3.10nMAssay Description:Agonist activity at human CCK1R V3.36A mutant expressed in CHO cells assessed as intracellular calcium response by fluorescence analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50329179(2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4...)
Affinity DataIC50:  4.5nMAssay Description:Displacement of [125I-BDZ-1] from human CCK1R T3.28V, T3.29S mutant expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Eil Therapeutics

US Patent
LigandPNGBDBM608721(US11697650, Compound 6 | US11697650, Example 31)
Affinity DataIC50: <5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Eil Therapeutics

US Patent
LigandPNGBDBM608720(US11697650, Compound 2 | US11697650, Example 30)
Affinity DataIC50: <5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Eil Therapeutics

US Patent
LigandPNGBDBM608719(US11697650, Compound 7 | US11697650, Example 28)
Affinity DataIC50: <5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Eil Therapeutics

US Patent
LigandPNGBDBM608716(US11697650, Compound 9 | US11697650, Example 25)
Affinity DataIC50: <5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Eil Therapeutics

US Patent
LigandPNGBDBM608706(US11697650, Compound 5 | US11697650, Example 15)
Affinity DataIC50: <5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Eil Therapeutics

US Patent
LigandPNGBDBM608704(US11697650, Compound 3 | US11697650, Example 13)
Affinity DataIC50: <5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Eil Therapeutics

US Patent
LigandPNGBDBM608702(US11697650, Compound 33 | US11697650, Example 11)
Affinity DataIC50: <5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Eil Therapeutics

US Patent
LigandPNGBDBM608700(N-(4-hydroxyphenyl)-N-(2-methoxybenzyl)-3-(6-{[(3S...)
Affinity DataIC50: <5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Eil Therapeutics

US Patent
LigandPNGBDBM608413(N-(2-fluorobenzyl)-N-(4-hydroxyphenyl)-3-(6-{[(3S)...)
Affinity DataIC50: <5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Eil Therapeutics

US Patent
LigandPNGBDBM608408(N-(4-hydroxyphenyl)-N-(2-methylbenzyl)-3-(6-{[(3S)...)
Affinity DataIC50: <5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Eil Therapeutics

US Patent
LigandPNGBDBM608731(US11697650, Compound 48 | US11697650, Example 42)
Affinity DataIC50: <5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Eil Therapeutics

US Patent
LigandPNGBDBM608725(US11697650, Compound 8 | US11697650, Example 37)
Affinity DataIC50: <5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Eil Therapeutics

US Patent
LigandPNGBDBM608724(US11697650, Compound 1 | US11697650, Example 35)
Affinity DataIC50: <5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Mayo Clinic

Curated by ChEMBL
LigandPNGBDBM50380728(CHEMBL2017835)
Affinity DataIC50:  7.20nMAssay Description:Displacement of [125I-BDZ-1] from human CCK1R T3.28V, T3.29S mutant expressed in CHO cells after 60 mins by scintillation counterMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Eil Therapeutics

US Patent
LigandPNGBDBM608723(US11697650, Compound 13 | US11697650, Example 33)
Affinity DataIC50:  7.5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Eil Therapeutics

US Patent
LigandPNGBDBM608406(N-benzyl-N-(4-hydroxyphenyl)-3-(6-{[(3S)-3-(morpho...)
Affinity DataIC50:  7.5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetApoptosis regulator Bcl-2(Homo sapiens (Human))
Eil Therapeutics

US Patent
LigandPNGBDBM608703(US11697650, Compound 19 | US11697650, Example 12)
Affinity DataIC50:  7.5nMAssay Description:The following assay concentrations and times were used: 3 ng BCL-2, 5 μl of 1:100 anti-His Tb-labeled donor, 5 μl of 1:100 Dye-labeled acce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 295 total ) | Next | Last >>
Jump to: